medicilon logo
CN

Blog

Challenges and Opportunities of Cardiovascular Drugs in the Trillion-Dollar Market

Challenges and Opportunities of Cardiovascular Drugs in the Trillion-Dollar Market

Currently, cardiovascular disease (CVD) has become an important topic in the global public health. According to the “2022 Report on Cardiovascular Health and Diseases in China,” the number of cardiovascular disease patients in China is as high as 330 million, including 245 million hypertensive patients, 13 million stroke patients, 11.39 million coronary heart disease patients, and 8.9 million heart failure patients.

Read More »
ion chromatography

Questions and answers about ion chromatography

In the research and development of new drugs, ion chromatography technology is widely used in drug ingredient analysis, content detection and impurity control. Ion chromatography technology makes up for the shortcomings of conventional chromatography technology in drug research and development, providing reliable technical support for drug quality control and drug safety evaluation.

Read More »
Medicilon DMPK & Bioanalysis Services

Medicilon DMPK & Bioanalysis Services

Medicilon’s DMPK&BA department offers our clients a broad spectrum of high quality services in the areas of in vitro ADMET, in vivo PK & BA, and non-GLP Tox services for both small and large molecule drugs, such as proteins, antibodies, oliogonucleotides, ADC and new modalities.

Read More »

You might be interested in:

Scroll to Top